Hair, Nail, and Umbilical Cord Testing for Phenibut, Medetomidine, and Tianeptine
Showing: February 2025
We are excited to announce the addition phenibut, medetomidine, and tianeptine to our umbilical cord tissue, hair, and nail testing menus. These substances can be ordered as an individual test or an add-on to any umbilical cord tissue, hair, or nail drug panel beginning March 10, 2025.
Click here to learn more about our new phenibut, medetomidine, and tianeptine testing.
For more information on hair testing click here, for more information on nail testing click here, and for more information on umbilical cord tissue testing click here.
- Hair, Nail, and Umbilical Cord Testing for Phenibut, Medetomidine, and Tianeptine
- Umbilical Cord Tissue Testing for SSRIs
- A Comparison of Turnaround-Times for Two Popular Specimen Types Used for Newborn Toxicology: Meconium and Umbilical Cord Tissue
- Using Umbilical Cord Tissue to Identify Prenatal Ethanol Exposure and Co-exposure to Other Commonly Misused Substances
- Toxicology as a Diagnostic Tool to Identify the Misuse of Drugs in the Perinatal Period
- Specimen Delay
- Drug Classes and Neurotransmitters: Amphetamine, Cocaine, and Hallucinogens
- Environmental Exposure Testing for Delta-8 THC, Delta-9 THC, Delta-10 THC, and CBD
- February 2025 (1)
- October 2024 (5)
- March 2024 (1)
- February 2024 (1)
- January 2024 (3)
- December 2023 (1)